Viewing Study NCT06888492


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-30 @ 3:20 AM
Study NCT ID: NCT06888492
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-21
First Post: 2025-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)
Sponsor: Hangzhou Jiayin Biotech Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module